Temporal analysis of hospitalizations for Diabetes Mellitus in Brazil and its relationship with COVID-19: ecological study


  • Amanda Chabrour Chehadi
  • Beatriz da Silva Morandi
  • Gelma Maria Jerônymo Vieira Neves
  • Maria Paula Cerutti Dumoncel
  • Murillo Martins Cardoso
  • Sandra Maria Barbalho




COVID-19, diabetes mellitus, hospitalization, mortality


Diabetes mellitus (DM) is a condition resulting from changes in cartilage or the effect of insulin, resulting in chronic hyperglycemia. In diabetic patients, the presence of COVID-19 increases the rates of serious complications and there is a greater risk of mortality. To analyze the phenotypic characteristics of hospitalizations and mortality rates due to DM in Brazil through epidemiological data and their relationship with COVID-19. This is an observational, descriptive, cross-sectional, quantitative and retrospective study; carried out with analysis of secondary data on hospitalizations for DM, through the Information Technology Department of the Unified Health System (DataSUS) in the period from 2018 to 2022 in Brazil. Variables of year of service, region, race/color, age group and sex were considered. In the present analysis, there is a greater MT in the Southeast and Northeast regions of Brazil. In terms of gender distribution, the highest prevalence is in males (51.05%), but with lower MT than females (2.69 x 2.84), with the population aged between 50 and over. 80 years old with higher percentages of international and TM. Finally, it is clear that the Brown race required more hospitalizations (41.68%), while the Black race was associated with the highest mortality rates. In the present study, it is possible to analyze that the phenotypic characteristics of diabetic patients influence the mortality prognosis, providing the basis for further research with the aim of analyzing the mechanisms that lead to the epidemiological aspects with greater prevalence of TM.


ARAÚJO, LEVIMAR ROCHA. DADOS EPIDEMIOLÓGICOS. [s.l: s.n.]. Disponível em: <https://profissional.diabetes.org.br/wp-content/uploads/2023/06/Dados-Epidemiologicos-SBD_comT1Dindex.pdf>.

BARBALHO, SM, et.al. Organokines in COVID-19: A Systematic Review. Cells, v. 12, n. 10, 2023 May 9. Doi: 10.3390/cells12101349. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216619/.

BARONE, M. T. U. et al. COVID-19 impact on people with diabetes in South and Central America (SACA region). Diabetes Research and Clinical Practice, v. 166, p. 108301, 1 ago. 2020. Doi: 10.1016/j.diabres.2020.108301. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332429/. Acesso em: 30 de julho de 2023.

BARRETO, E. A. et al. COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis. Proc Natl Acad Sci U S A, v. 120, n. 21, 15 maio 2023. Doi: 10.1073/pnas.2217119120. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214153/. Acesso em: 28 de agosto de 2023.

BIGONI, A. et al. Brazil’s health system functionality amidst of the COVID-19 pandemic: An analysis of resilience. The Lancet Regional Health – Americas, v. 10, n. 100222, 1 jun. 2022. DOI: 10.1016/j.lana.2022.100222. Disponível em: https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(22)00039-4/fulltext#. Acesso em: 30 de julho de 2023.

BRAFFETT, B. H. et al. Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes. JAMA Network Open, v. 5, n. 9, p. e2230710, 8 set. 2022. Doi: 10.1001/jamanetworkopen.2022.30710. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459657/. Acesso em: 30 de agosto de 2023.

CAO, H. et al. Bidirectional causal associations between type 2 diabetes and COVID-19. Journal of Medical Virology, v. 95, n. 1, p. e28100, 1 jan. 2023. Doi: 10.1002/jmv.28100. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538258/#jmv28100-bib-0041. Acesso em: 28 de agosto de 2023.

CARIOU, B. et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia, 29 maio 2020. Doi: 10.1007/s00125-020-05180-x. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256180/. Acesso em: 28 de agosto de 2023.

CINISLIOGLU, A. E. et al. The relationship of serum testosterone levels with the clinical course and prognosis of COVID‐19 disease in male patients: A prospective study. Andrology, v. 10, n. 1, p. 24–33, 2 ago. 2021. Doi: 10.1111/andr.13081 . Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444851/. Acesso em: 30 de agosto de 2023.

CORDAS, S. et al. The association of body mass index and odds of type 2 diabetes mellitus varies by race/ethnicity. Public Health, v. 215, p. 27–30, 1 fev. 2023. Doi: https://doi.org/10.1016/j.puhe.2022.11.017. Disponível em: https://www.sciencedirect.com/science/article/pii/S003335062200333X?via%3Dihub#bib6. Acesso em: 28 de agosto de 2023.

DA SILVA, JOÃO PAULO TEIXEIRA. A regionalização da saúde no brasil: uma avaliação a partir da rede hospitalar natal/rn 2018 centro de ciências da saúde programa de pós-graduação em saúde coletiva. [s.l: s.n.]. Disponível em: https://repositorio.ufrn.br/bitstream/123456789/28036/1/Regionaliza%c3%a7%c3%a3osa%c3%badeBrasil_Silva_2019.pdf. Acesso em: 28 de agosto de 2023.

DAHLIA, D. et al. Death risk among COVID-19 patients with diabetes mellitus. Journal of Public Health in Africa, v. 13, n. s2, 7 dez. 2022. Doi: 10.4081/jphia.2022.2399. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367039/. Acesso em: 30 de agosto de 2023.

DALLAVALASA, S. et al. COVID-19: Diabetes Perspective—Pathophysiology and Management. Pathogens, v. 12, n. 2, p. 184, 25 jan. 2023. Doi: 10.3390/pathogens12020184 Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967788/ . Acesso em: 28 de agosto de 2023.

DE MIGUEL-YANES, J. M. et al. Impact of Type 2 Diabetes Mellitus on the Incidence and Outcomes of COVID-19 Needing Hospital Admission According to Sex: Retrospective Cohort Study Using Hospital Discharge Data in Spain, Year 2020. Journal of Clinical Medicine, v. 11, n. 9, p. 2654, 9 maio 2022. Doi: 10.3390/jcm11092654. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104185/. Acesso em: 28 de agosto de 2023.

Desigualdades Sociais por Cor ou Raça no Brasil Estudos e Pesquisas • Informação Demográfica e Socioeconômica • n.48 2a edição Introdução 1. [s.l: s.n.]. Disponível em: < https://biblioteca.ibge.gov.br/visualizacao/livros/liv101972_informativo.pdf>.

DO, P. Panorama do Censo 2022. Disponível em: <https://censo2022.ibge.gov.br/panorama/>. Acesso em: 28 jun. 2023.

FERNÁNDEZ-GARCÍA, JOSÉ CARLOS, et al. Metformin, testosterone, or both in men with obesity and low testosterone: A double-blind, parallel-group, randomized controlled trial. Metabolism-clinical and Experimental, v. 136, p. 155290–155290, 1 ago. 2022. DOI:https://doi.org/10.1016/j.metabol.2022.155290. Disponível em: https://www.metabolismjournal.com/article/S0026-0495(22)00168-8/fulltext. Acesso em: 30 de agosto de 2023.

FLORÊNCIO, R. B. et al. Diabetes mellitus hospitalization and mortality rate according to a national database in Brazil: a longitudinal study. BMC Public Health, v. 21, p. 403, 25 fev. 2021. Doi: 10.1186/s12889-021-10438-z. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908752/. Acesso em: 28 de agosto de 2023.

FLOYD, J. S. et al. Association Between Diabetes Severity and Risks of COVID-19 Infection and Outcomes. Journal of General Internal Medicine, v. 38, n. 6, p. 1484–1492, 16 fev. 2023. Doi: 10.1007/s11606-023-08076-9. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933797/. Acesso em: 28 de agosto de 2023.

GARCES, THIAGO SANTOS et al. Relationship between social development indicators and mortality due to Diabetes Mellitus in Brazil: a space-time analysis. Revista Latino-americana De Enfermagem, v. 31, 1 dez. 2023. Doi: 10.1590/1518-8345.6592.3972. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424900/. Acesso em: 28 de agosto de 2023.

GOVENDER, N. et al. Insulin resistance in COVID-19 and diabetes. Primary Care Diabetes, v. 15, n. 4, p. 629-634, april 2021. Doi: 10.1016/j.pcd.2021.04.004. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031259/. Acesso em: 30 de julho de 2023.

HARDING, J. L. et al. The Bidirectional Association Between Diabetes and Long-COVID-19 – A Systematic Review. Diabetes Research and Clinical Practice, p. 110202, dez. 2022. Doi: 10.1016/j.diabres.2022.110202. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727969/. Acesso em: 15 de agosto de 2023.

HARREITER, JÜRGEN; RODEN, M. Diabetes mellitus: definition, classification, diagnosis, screening and prevention (Update 2023). Wiener Klinische Wochenschrift, v. 135, n. S1, p. 7–17, 1 jan. 2023. Doi: 10.1007/s00508-022-02122-y. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133036/. Acesso em: 15 de agosto de 2023.

HILL-BRIGGS, F. et al. Social Determinants of Health, Race, and Diabetes Population Health Improvement: Black/African Americans as a Population Exemplar. Current Diabetes Reports, v. 22, n. 3, p. 117-128, 3 mar. 2022. Doi: 10.1007/s11892-022-01454-3. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891426/. Acesso em: 28 de agosto de 2023.

HOLMAN, N. et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. The Lancet Diabetes & Endocrinology, v. 8, n. 10, 13 ago. 2020. doi: 10.1016/S2213-8587(20)30271-0. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426091/. Acesso em: 30 de agosto de 2023.

KAUTZKY-WILLER, A. et al. Geschlechtsspezifische Aspekte bei Prädiabetes und Diabetes mellitus – klinische Empfehlungen (Update 2023). Wien Klin Wochenschr, v. 135, n. S1, p. 275–285, 1 jan. 2023. Doi: 10.1007/s00508-023-02185-5. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133065/. Acesso em: 30 de julho de 2023.

KAUTZKY-WILLER, A.; LEUTNER, M.; HARREITER, J. Sex differences in type 2 diabetes. Diabetologia, v. 66, n. 6, p. 986-1002, 10 mar. 2023. Doi: 10.1007/s00125-023-05891-x. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163139/. Acesso em: 15 de agosto de 2023.

KNAUL, F. M. et al. Punt Politics as Failure of Health System Stewardship: Evidence from the COVID-19 Pandemic Response in Brazil and Mexico. The Lancet Regional Health – Americas, v. 4, 1 dez. 2021. Doi: 10.1016/j.lana.2021.100086. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514423/. Acesso em: 30 de julho de 2023.

KUMAR, A. et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes & Metabolic Syndrome, v. 14, n. 4, p. 535–545, 2020. Doi: 10.1016/j.dsx.2020.04.044. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200339/. Acesso em: 30 de julho de 2023.

MCGURNAGHAN, S. J. et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. The Lancet Diabetes & Endocrinology, v. 9, n. 2, p. 82-93, 23 dez. 2020. Doi: 10.1016/S2213-8587(20)30405-8. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832778/. Acesso em: 30 de agosto de 2023.

MINISTÉRIO DA SAÚDE - Boletim Epidemiológico Vol.53 No45. Disponível em: <https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/edicoes/2022/boletim-epidemiologico-vol-53-no45/view>.

MIZUKAMI, H.; KUDOH, K. Diversity of Pathophysiology in Type 2 Diabetes Revealed by Islet Pathology. Journal of Diabetes Investigation, v. 13, n. 1, 25 set. 2021. Doi: 10.1111/jdi.13679. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756316/. Acesso em: 15 de agosto de 2023.

Número de pessoas com diabetes nas Américas mais do que triplica em três décadas, afirma relatório da OPAS - OPAS/OMS | Organização Pan-Americana da Saúde. Disponível em: <https://www.paho.org/pt/noticias/11-11-2022-numero-pessoas-com-diabetes-nas-americas-mais-do-que-triplica-em-tres-decadas>.

OGUZ, SEDA HANIFE; YILDIZ, BULENT OKAN. Endocrine Disorders and COVID-19. Annual Review of Medicine, vol. 74, p. 75-88, 28 September 2022. Doi: https://doi.org/10.1146/annurev-med-043021- 033509. Disponível em: https://www.annualreviews.org/doi/pdf/10.1146/annurev-med-043021-033509. Acesso em: 28 de agosto de 2023.

Quase 80% da população brasileira que depende do SUS se autodeclara negra. Disponível em: <https://brasil.un.org/pt-br/78576-quase-80-da-popula%C3%A7%C3%A3o-brasileira-que-depende-do-sus-se-autodeclara-negra>.

ROSENGREN, A.; PIGI DIKAIOU. Cardiovascular outcomes in type 1 and type 2 diabetes. DIABETOLOGIA 2023, v. 66, n. 3, p. 425–437, 14 jan. 2023. Doi: 10.1007/s00125-022-05857-5. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840171/. Acesso em: 28 de agosto de 2023.

SANTOS, C. et al. Diabetes mellitus: relation between cardiovascular events and pharmacological treatment. PubMed, v. 94, n. 2, p. e2023012–e2023012, 24 abr. 2023. Doi: 10.23750/abm.v94i2.13685. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210556/. Acesso em: 28 de agosto de 2023.

SHI, Q. et al. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care, v. 43, n. 7, p. 1382-1391, 14 maio 2020. Doi: https://doi.org/10.2337/dc20-0598. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32409504/. Acesso em: 30 de julho de 2023.

SOTT, M. K.; BENDER, M. S.; DA SILVA BAUM, K. Covid-19 Outbreak in Brazil: Health, Social, Political, and Economic Implications. International Journal of Health Services, v. 52, n. 4, p. 442–454, 4 set. 2022. Doi: 10.1177/00207314221122658. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445630/. Acesso em: 30 de julho de 2023.

STEENBLOCK, C. et al. Diabetes and COVID-19: Short- and Long-Term Consequences. Hormone and Metabolic Research, v. 54, n. 08, p. 503–509, 20 jun. 2022. Doi: 10.1055/a-1878-9566. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363150/. Acesso em: 30 de julho de 2023.

TRAMUNT, B. et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia, v. 63, n. 3, p. 453–461, 21 nov. 2019. Doi: 10.1007/s00125-019-05040-3. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997275/. Acesso em: 15 de agosto de 2023.

WITTERT, G. A.; GROSSMANN, M. Obesity, type 2 diabetes, and testosterone in ageing men. Rev. Endocr. Metab. Disord., v. 23, n. 6, p. 1233–1242, 14 jul. 2022. Doi: 10.1007/s11154-022-09746-5. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789005/. Acesso em: 30 de agosto de 2023.

WONG, R. et al. Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence. Curr Diab Rep. 2023, v. 23, n. 8, p, 207–216, 7 jun. 2023. Doi: 10.1007/s11892-023-01515-1. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244847/. Acesso em: 28 de agosto de 2023.

YAO, X. et al. Age at diagnosis, diabetes duration and the risk of cardiovascular disease in patients with diabetes mellitus: a cross-sectional study. Frontiers in Endocrinology, v. 14, 8 maio 2023. Doi: 10.3389/fendo.2023.1131395. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200881/. Acesso em: 15 de agosto de 2023.

ZAHEDI, M. et al. A Review of Hyperglycemia in COVID-19. Cureus, v. 15, n. 4, 12 abr. 2023. Doi: 10.7759/cureus.37487. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181889/. Acesso em: 28 de agosto de 2023.

ZHENG, S. et al. Serum level of testosterone predicts disease severity of male COVID-19 patients and is related to T-cell immune modulation by transcriptome analysis. Clinica Chimica Acta; International Journal of Clinical Chemistry, v. 524, p. 132–138, 1 jan. 2022. Doi: 10.1016/j.cca.2021.11.006 . Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585551/. Acesso em: 30 de agosto de 2023.



How to Cite

Chehadi, A. C., Morandi, B. da S., Neves, G. M. J. V., Dumoncel, M. P. C., Cardoso, M. M., & Barbalho, S. M. (2024). Temporal analysis of hospitalizations for Diabetes Mellitus in Brazil and its relationship with COVID-19: ecological study. CONTRIBUCIONES A LAS CIENCIAS SOCIALES, 17(2), e4078. https://doi.org/10.55905/revconv.17n.2-052